Monday, April 28, 2014
Low Testosterone May be Associated with Increased Risk of Premature Death in Men with CKD Stages 3–4
Sunday, April 27, 2014
Monday, April 14, 2014
Friday, April 11, 2014
Among 1998 lupus patients with ESRD, the 1-year, 5-year, 10-year patient survival rates were best for those who underwent kidney transplantation (100%, 98.1%, and 94.4%, respectively), followed by peritoneal dialysis (88.3%, 79.1%, and 76%, respectively), and hemodialysis (53.6%, 46.0%, and 41.6%, respectively). For those who underwent kidney transplantation within 1 year after ESRD, no significant worse patient survival and graft survival were observed than for those who underwent transplantation 1 year later. The findings are published in Transplantation Proceedings.
The Wall Street Journal (3/31, MacLucas, Subscription Publication) reports that Novartis AG said that it has halted a study of a heart failure medication known as LCZ696 after researchers found that the medication was shown to benefit patients.
The Bloomberg News (3/31, von Schaper) reports that investigators “followed more than 8,000 patients with a certain type of heart failure who received either the Novartis drug or enalapril, the standard treatment.” The researchers found that patients given the experimental medication “lived longer without being hospitalized than” the “group who received” enalapril.
Reuters (3/31) explains that the trial was evaluating the new medication in individuals with reduced ejection fraction chronic heart failure
The New York Times (3/30, Grady, Subscription Publication) reported on the unexpected finding of “a landmark study” that found renal denervation may not benefit individuals with uncontrolled hypertension. The study of 535 patients split them into groups that received the actual procedure or a fake procedure that was designed to fool patients. After six months, “both groups experienced drops in blood pressure, but there was no significant difference.”
Reuters (3/31, Emery, Berkrot) reports that the study was presented at the American College of Cardiology meeting and published in the New England Journal of Medicine.
Forbes (3/30) contributor Larry Husten wrote that the researchers “noted that despite the widespread hype, enough information was available to predict that the trial would not produce the large, dramatic reductions in BP that many experts had predicted.” Medscape (3/30, O'Riordan) also covers the story.
Bloomberg News (3/29) reported that Medtronic Inc. artificial aortic valve system, inserted without opening the chest, “reduced patient death rates more than open-heart surgery in the first study to ever record such a finding.” The article noted that about “14 percent of patients in the 747-person trial died within a year of treatment with Medtronic’s CoreValve,” compared with “19 percent of those who underwent open-heart surgery died,” citing a study unveiled at the American College of Cardiology meeting in Washington. Bloomberg pointed out that the results “were so robust” that US regulators noted “they won’t require the standard review by outside experts before approving the device.”
Medscape (3/31) reports that Dr. David Adams of Mount Sinai Medical Center in New York presented the results, which were also published in the New England Journal of Medicine.
NBC Nightly News (3/30, story 5, 0:40, Holt) reported, “Research presented at the American College of Cardiology” meeting suggests that diet drinks may increase heart risks in older women.
On its website, NBC News (3/30, Fox) reported that investigators “studied nearly 60,000 middle-aged women taking part in a decade-long study of women’s health.” Participants “filled out a questionnaire on food and drinks as part of the study, including detailed questions on diet sodas and diet fruit drinks.” The investigators, “after just under nine years...checked to see what happened to the womens’ health.”
The Huffington Post reported that “women who consumed two or more diet drinks daily were not only 30 percent more likely to suffer heart attacks and strokes, they were 50 percent more likely to die from some sort of cardiovascular disease, when compared with women who never or rarely drank diet drinks.” Also covering the story were Reuters (3/30, Pierson, Berkrot) reports, HealthDay(3/31), Medscape (3/30, Busko), MedPage Today (3/30, Phend).
FOX News (3/28, Rettner) carries a LiveScience story reporting that “rates of new cancer cases in the United States have fallen slightly in recent years, according to a new” CDC report to be published in Morbidity and Mortality Weekly Report. The report indicated that “between 2009 and 2010, the rate of invasive cancer...dropped from 459 new cases per 100,000 people, to 446 new cases per 100,000 people.”
HealthDay (3/28, Preidt) reports, “By tumor type, rates of advanced disease were highest for cancers of the prostate (126 per 100,000), female breast (119 per 100,000), lung and bronchial airways (62 per 100,000) and colon/rectum (40 per 100,000).” The data indicated that “prostate, lung and colorectal cancers were the most common advanced tumors among men, while breast, lung, colorectal and uterine cancers were most common among women.”
Medscape (3/28, Mulcahy) reports that the data indicated that “rates of new cancer cases were higher in men than in women (503 vs 405 per 100,000), highest in black patients (455 per 100,000), and ranged by state.”
Nutrition needs change as we age, and that’s why during week four of National Nutrition Month we’re sharing healthy eating tips so you can make good food decisions your entire life.
Here’s what you need to know:
Planning and preparing your own meals lets you control your portion sizes.
Your sense of smell and taste can fade as you age. Learn what causes it and ways to help improve the taste of food.
As you age, you may want to take dietary supplements to round out your nutrition. Learn which ones are best to take.